You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0230 Assessment of Safety, Pharmacokinetics and Pharmacodynamics of A Novel anti-CD40 Monoclonal antibody, CFZ533, in Healthy Volunteers and in Rheumatoid Arthritis Patients

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0230 Assessment of Safety, Pharmacokinetics and Pharmacodynamics of A Novel anti-CD40 Monoclonal antibody, CFZ533, in Healthy Volunteers and in Rheumatoid Arthritis Patients

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016200
Aug 2016502
Sep 2016304
Oct 20161606
Nov 20161203
Dec 20162300
Jan 20171802
Feb 20171305
Mar 20172205
Apr 2017501
May 20172403
Jun 20173101
Jul 20174600
Aug 20175804
Sep 20174201
Oct 20175403
Nov 20176605
Dec 20177605
Jan 20189807
Feb 20187902
Mar 20187400
Apr 201812405
May 20187803
Jun 20188405
Jul 20187204
Aug 20183604
Sep 20184801
Oct 20183801
Nov 20185803
Dec 20184401
Jan 20197406
Feb 20194404
Mar 20194103
Apr 20194502
May 201910006
Jun 20194501
Jul 20192500
Aug 20197202
Sep 20195501
Oct 20196901
Nov 20197102
Dec 20193501
Jan 20204901
Feb 20201200
Mar 20202200
Apr 20201500
May 20201600
Jun 20201800
Jul 20202602
Aug 20202000
Sep 20205900
Oct 20202602
Nov 2020800
Dec 20201400
Jan 20211200
Feb 20211800
Mar 20215700
Apr 20211400
May 20212000
Jun 2021101
Oct 20211301
Nov 20211502
Dec 20212200
Jan 2022800
Feb 20221400
Mar 20221601
Apr 20221400
May 20221800
Jun 20221700
Jul 20221101
Aug 20221800
Sep 20221003
Oct 20221600
Nov 20222000
Dec 20221501
Jan 2023700
Feb 2023900
Mar 20232301
Apr 2023800
May 2023900
Jul 2023300
Aug 2023602
Sep 2023800
Oct 20231001
Nov 20232901
Dec 20231601
Jan 2024600
Feb 20241200
Mar 2024200
Total28070136